Clinical applications
Cardiovascular regeneration
Vascular grafts, heart-valve scaffolds, computational models, biosensors and device-based treatments for cardiovascular disease.
Overview
About this research
Vascular grafts, heart-valve scaffolds, computational models, biosensors and device-based treatments for cardiovascular disease.
People
Research team
Director of TERG · Professor of Bioengineering and Regenerative Medicine · Principal Investigator
Fergal O’Brien
Biomaterials · Tissue engineering · Regenerative medicine
Head of Department · Principal Investigator
Garry Duffy
Translational medicine · Medical devices · Chronic wound technologies
Senior Lecturer · Principal Investigator
Aamir Hameed
Bioengineering · Biomaterials · Cardiothoracic surgery
Outputs
Related publications
Patient-specific investigation into plaque rupture risk due to catheter tracking during TAVR
Miniature Implantable Left Atrial/Ventricular Pump to Treat Symptoms of Heart Failure With Preserved Ejection Fraction: A Novel Device Treatment
Computational Investigation of Vessel Injury Due to Catheter Tracking During Transcatheter Aortic Valve Replacement
A European update on transcatheter aortic valve implantation (TAVI) in the COVID era.
Device-Based Solutions to Improve Cardiac Physiology and Hemodynamics in Heart Failure With Preserved Ejection Fraction.
Towards the use of localised delivery strategies to counteract cancer therapy-induced cardiotoxicities.
Resveratrol significantly improves cell survival in comparison to dexrazoxane and carvedilol in a h9c2 model of doxorubicin induced cardiotoxicity.
Collaborate
Bring a problem worth solving.
We welcome conversations with academic, clinical and industry partners whose expertise can create a stronger route to impact.
Contact the lab